Toceranib
Toceranib phosphate is an orally active inhibitor of tyrosine kinase (RTK) receptor, and it potently inhibits PDGFR, VEGFR, and Kit (with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively), has antitumor and antiangiogenic activity.Administration of toceranib significantly decreased the number and percentage of Treg in the peripheral blood of dogs with cancer. Dogs receiving toceranib and CYC demonstrated a significant increase in serum concentrations of IFN-γ, which was inversely correlated with Treg numbers after 6 weeks of combination treatment.
Product Specifications
CAS Number
356068-94-5
Product Name Alternative
SU11654, PHA 291639E
Purity
>98% (HPLC)
Solubility
DMSO:2.4 mg/mL (6.05 mM; Need ultrasonic)
Smiles
Cc1[nH]c (\C=C2/C (=O) Nc3ccc (F) cc23) c (C) c1C (=O) NCCN1CCCC1
Molecular Formula
C22H25FN4O2
Molecular Weight
396.46
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Bovine Seizure 6-like protein 2 (SEZ6L2) , partial
Recombinant Bovine Seizure 6-like protein 2 (SEZ6L2) , partial
Recombinant Bovine Seizure 6-like protein 2 (SEZ6L2) , partial
Recombinant Bovine Seizure 6-like protein 2 (SEZ6L2) , partial
SMN1 (Survival of Motor Neuron 1, SMA, SMN, SMA1, SMA2, SMA3, SMA4, SMNT, BCD541, GEMIN1, TDRD16A, T-BCD541) (FITC)